IBDEI2U8 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,45266,1,4,0)
 ;;=4^C50.911
 ;;^UTILITY(U,$J,358.3,45266,2)
 ;;=^5001195
 ;;^UTILITY(U,$J,358.3,45267,0)
 ;;=C64.1^^172^2261^13
 ;;^UTILITY(U,$J,358.3,45267,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45267,1,3,0)
 ;;=3^Malignant neoplasm of right kidney, except renal pelvis
 ;;^UTILITY(U,$J,358.3,45267,1,4,0)
 ;;=4^C64.1
 ;;^UTILITY(U,$J,358.3,45267,2)
 ;;=^5001248
 ;;^UTILITY(U,$J,358.3,45268,0)
 ;;=C44.99^^172^2261^14
 ;;^UTILITY(U,$J,358.3,45268,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45268,1,3,0)
 ;;=3^Malignant neoplasm of skin,Oth Spec
 ;;^UTILITY(U,$J,358.3,45268,1,4,0)
 ;;=4^C44.99
 ;;^UTILITY(U,$J,358.3,45268,2)
 ;;=^5001094
 ;;^UTILITY(U,$J,358.3,45269,0)
 ;;=C79.51^^172^2261^15
 ;;^UTILITY(U,$J,358.3,45269,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45269,1,3,0)
 ;;=3^Secondary malignant neoplasm of bone
 ;;^UTILITY(U,$J,358.3,45269,1,4,0)
 ;;=4^C79.51
 ;;^UTILITY(U,$J,358.3,45269,2)
 ;;=^5001350
 ;;^UTILITY(U,$J,358.3,45270,0)
 ;;=C79.52^^172^2261^16
 ;;^UTILITY(U,$J,358.3,45270,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45270,1,3,0)
 ;;=3^Secondary malignant neoplasm of bone marrow
 ;;^UTILITY(U,$J,358.3,45270,1,4,0)
 ;;=4^C79.52
 ;;^UTILITY(U,$J,358.3,45270,2)
 ;;=^5001351
 ;;^UTILITY(U,$J,358.3,45271,0)
 ;;=D47.4^^172^2262^29
 ;;^UTILITY(U,$J,358.3,45271,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45271,1,3,0)
 ;;=3^Osteomyelofibrosis
 ;;^UTILITY(U,$J,358.3,45271,1,4,0)
 ;;=4^D47.4
 ;;^UTILITY(U,$J,358.3,45271,2)
 ;;=^5002259
 ;;^UTILITY(U,$J,358.3,45272,0)
 ;;=D50.9^^172^2262^1
 ;;^UTILITY(U,$J,358.3,45272,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45272,1,3,0)
 ;;=3^Anemia, iron deficiency
 ;;^UTILITY(U,$J,358.3,45272,1,4,0)
 ;;=4^D50.9
 ;;^UTILITY(U,$J,358.3,45272,2)
 ;;=^5002283
 ;;^UTILITY(U,$J,358.3,45273,0)
 ;;=D64.9^^172^2262^2
 ;;^UTILITY(U,$J,358.3,45273,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45273,1,3,0)
 ;;=3^Anemia, unspecified
 ;;^UTILITY(U,$J,358.3,45273,1,4,0)
 ;;=4^D64.9
 ;;^UTILITY(U,$J,358.3,45273,2)
 ;;=^5002351
 ;;^UTILITY(U,$J,358.3,45274,0)
 ;;=D75.89^^172^2262^3
 ;;^UTILITY(U,$J,358.3,45274,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45274,1,3,0)
 ;;=3^Blood & blood forming organ disease, oth spec
 ;;^UTILITY(U,$J,358.3,45274,1,4,0)
 ;;=4^D75.89
 ;;^UTILITY(U,$J,358.3,45274,2)
 ;;=^5002392
 ;;^UTILITY(U,$J,358.3,45275,0)
 ;;=D89.2^^172^2262^16
 ;;^UTILITY(U,$J,358.3,45275,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45275,1,3,0)
 ;;=3^Hypergammaglobulinemia, unspecified
 ;;^UTILITY(U,$J,358.3,45275,1,4,0)
 ;;=4^D89.2
 ;;^UTILITY(U,$J,358.3,45275,2)
 ;;=^5002455
 ;;^UTILITY(U,$J,358.3,45276,0)
 ;;=E03.9^^172^2262^24
 ;;^UTILITY(U,$J,358.3,45276,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45276,1,3,0)
 ;;=3^Hypothyroidism, unspecified
 ;;^UTILITY(U,$J,358.3,45276,1,4,0)
 ;;=4^E03.9
 ;;^UTILITY(U,$J,358.3,45276,2)
 ;;=^5002476
 ;;^UTILITY(U,$J,358.3,45277,0)
 ;;=E05.90^^172^2262^30
 ;;^UTILITY(U,$J,358.3,45277,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45277,1,3,0)
 ;;=3^Thyrotoxicosis w/o thyrotoxic crisis/storm
 ;;^UTILITY(U,$J,358.3,45277,1,4,0)
 ;;=4^E05.90
 ;;^UTILITY(U,$J,358.3,45277,2)
 ;;=^5002492
 ;;^UTILITY(U,$J,358.3,45278,0)
 ;;=E08.42^^172^2262^10
 ;;^UTILITY(U,$J,358.3,45278,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45278,1,3,0)
 ;;=3^DM d/t underlying condition w/ diabetic polyneuropathy
 ;;^UTILITY(U,$J,358.3,45278,1,4,0)
 ;;=4^E08.42
